ARTCLINE has completed patient enrolment in a 142-patient randomized study [...]

Just – Evotec Biologics has been selected by BARDA to [...]

PolyPid is preparing to submit a New Drug Application for [...]

Munich-based Ethris GmbH is part of a seven-organisation European consortium [...]

ViiV Healthcare, the global specialist HIV company majority owned by [...]

ViiV Healthcare will present new data from its long-acting and [...]

Circio has entered a research collaboration with the University of [...]

NeoVac has reported positive first-in-human Phase 1 and Phase 2 [...]

Biocomposites has launched its SYNICEM antibiotic-loaded preformed spacers in Canada, [...]

En Carta Diagnostics has received FDA Breakthrough Device Designation for [...]